These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24786700)
1. Germ cell cancer risk in DSD patients. Cools M Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700 [TBL] [Abstract][Full Text] [Related]
2. Managing the risk of germ cell tumourigenesis in disorders of sex development patients. Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655 [TBL] [Abstract][Full Text] [Related]
3. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology. Looijenga LHJ; Kao CS; Idrees MT Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757 [TBL] [Abstract][Full Text] [Related]
4. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975 [TBL] [Abstract][Full Text] [Related]
5. Gonadal tumours and DSD. Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153 [TBL] [Abstract][Full Text] [Related]
6. Tumor risk in disorders of sex development. Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977 [TBL] [Abstract][Full Text] [Related]
7. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106 [TBL] [Abstract][Full Text] [Related]
9. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. Wünsch L; Holterhus PM; Wessel L; Hiort O BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217 [TBL] [Abstract][Full Text] [Related]
10. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy. Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic parameters and their value in testicular tumors]. Bürgler W; Jaeger P Urologe A; 1986 May; 25(3):157-9. PubMed ID: 3016965 [TBL] [Abstract][Full Text] [Related]
12. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. Abacı A; Çatlı G; Berberoğlu M J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1019-27. PubMed ID: 25879315 [TBL] [Abstract][Full Text] [Related]
13. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development. Pyle LC; Nathanson KL Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305 [TBL] [Abstract][Full Text] [Related]
14. Neoplastic potential in patients with disorders of sexual differentiation. Beheshti M; Hardy BE; Mancer K; McLorie G; Churchill BM Urology; 1987 Apr; 29(4):404-7. PubMed ID: 3031862 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development. Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164 [TBL] [Abstract][Full Text] [Related]
17. Gonadal development and tumor formation at the crossroads of male and female sex determination. Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949 [TBL] [Abstract][Full Text] [Related]